Search
Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Search
Close this search box.

SEND Services 

SEND Services 

Enabling preclinical data compliance for regulatory filings

Syngene’s SEND services team helps research organizations comply with the US food and drug administration (FDA) agency’s approval process for investigational new drugs (IND), new drug applications (NDA), and biological license applications (BLA). We compile data from our client’s nonclinical studies into a consistent digital format using the standard exchange for nonclinical data (SEND) format, an implementation of the study data tabulation model (SDTM) standard for nonclinical studies.

Since 2018, we have successfully delivered over 2 million data points and converted more than ten manually captured standalone study datasets into the SEND format.

Capabilities

Our SEND services include the following:

  • In-house executed in vivostudies
  • Standalone in vivo toxicology studies performed by other contract research organizations (CRO)
  • Conversion of manually captured data from other CROs into SEND format

Data integrity

We maintain high data integrity using the latest technologies, including Pristima® software and Pinnacle 21, to validate datasets against FDA-specific SEND validation rules and ensure SEND IG compliance. After conducting quality checks, we compare the datasets with the original study report and document the differences in the non-clinical study data reviewer’s guide (nSDRG).

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements. To find out more, read our Privacy Policy and Cookies Policy.

To view or email, Please share your details view

To download, Please share your details